Claudin-18 isoform 2-specific CAR T-cell therapy (satri-cel) versus treatment of physician's choice for previously treated advanced gastric or gastro-oesophageal junction cancer (CT041-ST-01): a randomised, open-label, phase 2 trial
Peking University · Peking University Cancer Hospital · +37 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
96
total citations
- FWCI
- 76.41
- Percentile
- 100%
- References
- 29
Citations per year
Authors
34- CQChangsong QiCorresponding
Peking University, Peking University Cancer Hospital
- CLChang Liu
Ministry of Education
- ZPZhi Peng
Peking University, Peking University Cancer Hospital
- YZYanqiao Zhang
Harbin Medical University, Third Affiliated Hospital of Harbin Medical University
- JWJia Wei
Nanjing Drum Tower Hospital
Topics & keywords
Topics
Keywords
- Medicine
- Cancer
- Gastro-
- Internal medicine
- Gastroenterology
- Oncology
- Reflux
- Disease
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.